Skip to main content
Clinical Trials/NCT02761837
NCT02761837CompletedNot Applicable

The Breathe Well Program to Improve Asthma Outcomes

National Jewish Health1 site in 1 country14,978 target enrollmentStarted: October 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
14,978
Locations
1
Primary Endpoint
Asthma Exacerbations

Study Overview

Brief Summary

The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.

Detailed Description

Breathe Well uses the Kaiser Permanente Electronic Health Record (EHR) to identify asthma exacerbation risk factors. For patients with a history of frequent exacerbations or B-agonist overuse, the EHR notifies a nurse who uses an EHR-generated tailored clinical report and patient directed decision support tool to engage and empower patients to develop an action plan in collaboration with providers. EHR-templated notes and order sets facilitate care plan execution. Poor controller medication adherence or unaddressed smoking results in the patient being automatically enrolled in an IBCT medication refill or smoking cessation program. Breathe Well uses multiple EHR functions and a patient and provider team to address barriers to evidence-based asthma care for providers.The study will be conducted in 26 primary care clinics of Kaiser Permanente Colorado (KPCO) using a pragmatic clinical trial design. Up to 15,000 high-risk asthma patients will be assigned to Breathe Well or guideline-based usual care based on their clinic.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Masking Description

This is a pragmatic controlled trial. Participants randomized to the intervention group will know when they receive the intervention, which will consist of an automated contact by IVR call/text, or email.

Eligibility Criteria

Ages
19 Years to 99 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adults with ≥1 EHR of these indicators of an asthma care gap in the EHR will be eligible.
  • •B-agonist overfilling
  • •inhaled corticosteroid (ICS) underfilling
  • •current smoker
  • •asthma exacerbation in the last year

Exclusion Criteria

  • •limited life expectancy
  • •diagnosis of chronic obstructive pulmonary disease
  • •lack of a pharmacy benefit because medication use cannot be captured.

Arms & Interventions

IVR call/text

Active Comparator

Identify gaps in care and contact patients by IVR phone call or text

Intervention: IVR call/text (Behavioral)

Email

Active Comparator

Identify gaps in care and contact patients by email

Intervention: Email (Behavioral)

Outcomes

Primary Outcomes

Asthma Exacerbations

Time Frame: 12 months

Defined as number of urgent care visits, hospitalizations, or prescriptions of an oral corticosteroid

Secondary Outcomes

  • Controller medication adherence(12 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials